We report here the desensitization and internalization of the relaxin receptor (RXFP1) after agonist activation in both primary human decidual cells and HEK293 cells stably transfected with RXFP1. The importance of -arrestin 2 in these processes has also been demonstrated. Thus, in HEK-RXFP1 cells the desensitization of RXFP1 was significantly increased when -arrestin 2 was overexpressed. After relaxin activation, -arrestin 2 was translocated to the cell membrane and RXFP1 underwent rapid internalization. We have previously shown that RXFP1 forms dimers/oligomers during its biosynthesis and trafficking to the plasma membrane, we now show that internalization of RXFP1 occurs through this dimerization/oligomerization. In nonagonist stimulated cells, it is known that the majority of the RXFP1 is located intracellularly and was confirmed in the cells used here. Constitutive internalization of RXFP1 could account for this and indeed, slow but robust constitutive internalization, which was increased after agonist stimulation was demonstrated. A carboxyl-terminal deleted RXFP1 variant had a similar level of constitutive agonist-independent internalization as the wild-type RXFP1 but lost sensitivity to agonist stimulation. This demonstrated the importance of the carboxyl terminus in agonist-stimulated receptor internalization. These data suggest that the autocrine/paracrine actions of relaxin in the decidua are under additional controls at the level of expression of its receptor on the surface of its target cells. (Endocrinology 150: 2419 -2428, 2009) R elaxin is structurally related to insulin (1), and its main systemic source in pregnant women is the corpus luteum (2). Recent work has expanded its role to several important nonreproductive tissues: cardiovascular, renal, and lung tissues and in prostate and thyroid cancers (3-7). We have shown that human relaxin is produced by the maternal decidua during pregnancy and acts locally within the decidua and the apposed chorion (8, 9) by binding to these cells (10).The relaxin receptor, relaxin family peptide receptor (RXFP)-1, belongs to the G protein-coupled receptor (GPCR) superfamily and was originally named the leucine-rich repeat-containing G proteincoupled receptor (LGR)-7 (11) and most recently RXFP1. RXFP1 and the closely related RXFP2 are mosaic proteins containing an extracellular region with 10 leucine-rich repeats and seven-transmembrane helix domains. RXFP1 and RXFP2 are activated by their endogenous ligands, relaxin, and insulin-like peptide 3 (INSL3), respectively. Among the members of the LGR subfamily are the glycoprotein hormone receptors such as LH receptor (LHR), FSH receptor (FSHR), and TSH receptor (TSHR) (12). RXFP1 and RXFP2 belong to the LGR C subfamily distinguished by a unique low-density lipoprotein class A module (LDL-A) at their N termini. We demonstrated that the LDL-A module of RXFP1 has a role in receptor maturation, cell surface delivery, and ligand-induced receptor signaling (13). Mutations in the LDL-A module of RXFP2 affects the prop...